MVBMS Wins Aranesp Business

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

NEW YORK — Messner Vetere Berger McNamee Schmetterer/Euro RSCG has won advertising duties for Amgen’s Aranesp following a two-month review, the client confirmed. The New York shop competed against Bates, FCB and Cline, Davis & Mann, all New York, for the estimated $25 million account, sources said.

Aranesp, which was approved in September, is intended for the treatment of anemia in patients with chronic kidney disease.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in